124 related articles for article (PubMed ID: 27121112)
1. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
Bogusz AM; Bagg A
Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
[TBL] [Abstract][Full Text] [Related]
2. Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.
Buchner M; Müschen M
Curr Opin Hematol; 2014 Jul; 21(4):341-9. PubMed ID: 24811161
[TBL] [Abstract][Full Text] [Related]
3. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
[TBL] [Abstract][Full Text] [Related]
4. Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers.
Crane GM
Arch Pathol Lab Med; 2024 May; 148(5):e90-e95. PubMed ID: 37776258
[TBL] [Abstract][Full Text] [Related]
5. A review of the association between interleukin-10 and human B-cell malignancies.
Khatri VP; Caligiuri MA
Cancer Immunol Immunother; 1998 Jul; 46(5):239-44. PubMed ID: 9690451
[No Abstract] [Full Text] [Related]
6. The genetics of nodal marginal zone lymphoma.
Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.
Saba NS; Liu D; Herman SE; Underbayev C; Tian X; Behrend D; Weniger MA; Skarzynski M; Gyamfi J; Fontan L; Melnick A; Grant C; Roschewski M; Navarro A; Beà S; Pittaluga S; Dunleavy K; Wilson WH; Wiestner A
Blood; 2016 Jul; 128(1):82-92. PubMed ID: 27127301
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.
DE Braekeleer M; Tous C; Guéganic N; LE Bris MJ; Basinko A; Morel F; Douet-Guilbert N
Mol Clin Oncol; 2016 May; 4(5):682-694. PubMed ID: 27123263
[TBL] [Abstract][Full Text] [Related]
10. The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
Oscier D; Else M; Matutes E; Morilla R; Strefford JC; Catovsky D
Br J Haematol; 2016 Sep; 174(5):767-75. PubMed ID: 27151266
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
Onaindia A; Medeiros LJ; Patel KP
Mod Pathol; 2017 Oct; 30(10):1338-1366. PubMed ID: 28664939
[TBL] [Abstract][Full Text] [Related]
12. Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing.
Parker JD; Shen Y; Pleasance E; Li Y; Schein JE; Zhao Y; Moore R; Wegrzyn-Woltosz J; Savage KJ; Weng AP; Gascoyne RD; Jones S; Marra M; Laskin J; Karsan A
Cold Spring Harb Mol Case Stud; 2016 Mar; 2(2):a000679. PubMed ID: 27148583
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Gaidzik VI; Teleanu V; Papaemmanuil E; Weber D; Paschka P; Hahn J; Wallrabenstein T; Kolbinger B; Köhne CH; Horst HA; Brossart P; Held G; Kündgen A; Ringhoffer M; Götze K; Rummel M; Gerstung M; Campbell P; Kraus JM; Kestler HA; Thol F; Heuser M; Schlegelberger B; Ganser A; Bullinger L; Schlenk RF; Döhner K; Döhner H
Leukemia; 2016 Nov; 30(11):2160-2168. PubMed ID: 27137476
[TBL] [Abstract][Full Text] [Related]
14. BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.
Alhourani E; Othman MA; Melo JB; Carreira IM; Grygalewicz B; Vujić D; Zecević Z; Joksić G; Glaser A; Pohle B; Schlie C; Hauke S; Liehr T
Oncol Lett; 2016 May; 11(5):3240-3246. PubMed ID: 27123097
[TBL] [Abstract][Full Text] [Related]
15. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Herling CD; Klaumünzer M; Rocha CK; Altmüller J; Thiele H; Bahlo J; Kluth S; Crispatzu G; Herling M; Schiller J; Engelke A; Tausch E; Döhner H; Fischer K; Goede V; Nürnberg P; Reinhardt HC; Stilgenbauer S; Hallek M; Kreuzer KA
Blood; 2016 Jul; 128(3):395-404. PubMed ID: 27226433
[TBL] [Abstract][Full Text] [Related]
16. Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
Porwit A; Fend F; Kremer M; Orazi A; Safali M; van der Walt J
Histopathology; 2016 Sep; 69(3):349-73. PubMed ID: 27208429
[TBL] [Abstract][Full Text] [Related]
17. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.
Burger JA; Landau DA; Taylor-Weiner A; Bozic I; Zhang H; Sarosiek K; Wang L; Stewart C; Fan J; Hoellenriegel J; Sivina M; Dubuc AM; Fraser C; Han Y; Li S; Livak KJ; Zou L; Wan Y; Konoplev S; Sougnez C; Brown JR; Abruzzo LV; Carter SL; Keating MJ; Davids MS; Wierda WG; Cibulskis K; Zenz T; Werner L; Dal Cin P; Kharchencko P; Neuberg D; Kantarjian H; Lander E; Gabriel S; O'Brien S; Letai A; Weitz DA; Nowak MA; Getz G; Wu CJ
Nat Commun; 2016 May; 7():11589. PubMed ID: 27199251
[TBL] [Abstract][Full Text] [Related]
18. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Sutton LA; Young E; Baliakas P; Hadzidimitriou A; Moysiadis T; Plevova K; Rossi D; Kminkova J; Stalika E; Pedersen LB; Malcikova J; Agathangelidis A; Davis Z; Mansouri L; Scarfò L; Boudjoghra M; Navarro A; Muggen AF; Yan XJ; Nguyen-Khac F; Larrayoz M; Panagiotidis P; Chiorazzi N; Niemann CU; Belessi C; Campo E; Strefford JC; Langerak AW; Oscier D; Gaidano G; Pospisilova S; Davi F; Ghia P; Stamatopoulos K; Rosenquist R;
Haematologica; 2016 Aug; 101(8):959-67. PubMed ID: 27198719
[TBL] [Abstract][Full Text] [Related]
19. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.
Juskevicius D; Lorber T; Gsponer J; Perrina V; Ruiz C; Stenner-Liewen F; Dirnhofer S; Tzankov A
Leukemia; 2016 Dec; 30(12):2385-2395. PubMed ID: 27198204
[TBL] [Abstract][Full Text] [Related]
20. The curious origins of angioimmunoblastic T-cell lymphoma.
Cortés JR; Palomero T
Curr Opin Hematol; 2016 Jul; 23(4):434-43. PubMed ID: 27177312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
